Patients should be advised to report persistent or severe nausea, severe abdominal pain (which may indicate pancreatitis), symptoms of gallbladder disease, signs of thyroid tumors (neck mass, hoarseness, difficulty swallowing), or signs of hypoglycemia, particularly when tirzepatide is used in combination with insulin or sulfonylureas
This fixed-price model removes the financial uncertainty of escalating doses
The only thing that came out as something remotely reminiscent of an explanation was A1c the improvements in glycaemic control
If you want faster recovery, stronger tissue, and more durable results, stacked therapy is often the more rational strategy
Previous weight management attempts are another critical consideration